Drug guidance
Ferric derisomaltose for treating iron deficiency anemia
Condition
Blood and Immune System
2 January 2024
Published on 02 Jan 2024
Last Updated on 02 Jan 2024
Guidance Recommendations
The Ministry of Health’s Drug Advisory Committee has not recommended ferric derisomaltose for inclusion on the MOH List of Subsidised Drugs for treating iron deficiency anaemia due to unfavourable cost-effectiveness compared with ferric carboxymaltose at the price proposed by the manufacturer.
Ferric derisomaltose for treating iron deficiency anemia (Published 2 Jan 2024) [PDF, 89 KB]